Mirati Therapeutics Stock Gains 6%

Shares of Mirati Therapeutics, Inc. (MRTX) are currrently gaining over 6% on Wednesday morning.

MRTX is currently trading at $79.52, up $4.95 or 6.64%, on the Nasdaq. The stock opened its trading at $78.91 after closing Tuesday's trading at $74.57. The stock has traded between $32.96 and $195.99 in the past 52 week period.

Mirati Therapeutics, a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Follow RTT